BNP Paribas Financial Markets’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.8M Buy
425,947
+200,517
+89% +$5.55M 0.01% 995
2025
Q1
$5.01M Buy
225,430
+51,950
+30% +$1.15M ﹤0.01% 1264
2024
Q4
$3.43M Sell
173,480
-19,446
-10% -$385K ﹤0.01% 1404
2024
Q3
$4.82M Buy
192,926
+105,924
+122% +$2.65M ﹤0.01% 1025
2024
Q2
$1.62M Buy
87,002
+40,942
+89% +$764K ﹤0.01% 1443
2024
Q1
$909K Sell
46,060
-30,608
-40% -$604K ﹤0.01% 1944
2023
Q4
$1.34M Buy
76,668
+7,846
+11% +$138K ﹤0.01% 1602
2023
Q3
$1.2M Sell
68,822
-10,053
-13% -$175K ﹤0.01% 1636
2023
Q2
$1.11M Sell
78,875
-47,671
-38% -$671K ﹤0.01% 1591
2023
Q1
$1.36M Buy
126,546
+91,547
+262% +$985K ﹤0.01% 1586
2022
Q4
$524K Buy
34,999
+24,207
+224% +$363K ﹤0.01% 1922
2022
Q3
$139K Sell
10,792
-6,148
-36% -$78.9K ﹤0.01% 2939
2022
Q2
$164K Sell
16,940
-44,257
-72% -$429K ﹤0.01% 2542
2022
Q1
$608K Buy
61,197
+4,289
+8% +$42.6K ﹤0.01% 2109
2021
Q4
$670K Buy
56,908
+51,275
+910% +$604K ﹤0.01% 2258
2021
Q3
$64.2K Buy
5,633
+4,559
+424% +$51.9K ﹤0.01% 2850
2021
Q2
$15K Sell
1,074
-2,425
-69% -$33.8K ﹤0.01% 3023
2021
Q1
$64.8K Buy
3,499
+414
+13% +$7.66K ﹤0.01% 2960
2020
Q4
$54.5K Sell
3,085
-3,305
-52% -$58.4K ﹤0.01% 2860
2020
Q3
$97.9K Buy
6,390
+5,003
+361% +$76.6K ﹤0.01% 2513
2020
Q2
$35.3K Sell
1,387
-3,139
-69% -$80K ﹤0.01% 2550
2020
Q1
$70.1K Buy
4,526
+2,284
+102% +$35.4K ﹤0.01% 2777
2019
Q4
$24.8K Buy
2,242
+26
+1% +$288 ﹤0.01% 3270
2019
Q3
$18.9K Buy
2,216
+679
+44% +$5.78K ﹤0.01% 3331
2019
Q2
$20.8K Sell
1,537
-1,148
-43% -$15.5K ﹤0.01% 3256
2019
Q1
$48.5K Buy
2,685
+2,467
+1,132% +$44.6K ﹤0.01% 2921
2018
Q4
$6.12K Buy
218
+80
+58% +$2.25K ﹤0.01% 2838
2018
Q3
$3.52K Buy
+138
New +$3.52K ﹤0.01% 3497